Dirk Arnold is Professor of Medicine at the University of Hamburg, where he held the position as Medical Director of the University Cancer Center (UCCH) until 2012, and before as Assistant Professor and Chair of the Gastrointestinal Cancer Unit at the Martin Luther University Halle-Wittenberg, Halle, Germany, where he also received his training as Medical Oncologist, and specialist in Palliative Care. From 2012 to 2015, he served as Director of the Dept. Medical Oncology of the Klinik für Tumorbiologie, University Freiburg. In January 2016, he joined the CUF Hospitals in Lisbon, Portugal, as Director of Oncology services.
Dr Arnold’s main research interests include the treatment of gastrointestinal and genitourinary cancers, focusing on molecular-targeted therapies, immunotherapy, multimodal treatment strategies and early drug developments. He is also interested into research network structures and methodology of clinical research and benefit evaluation procedures, as well as in palliative and supportive care.
Dr Arnold is the Chairman of the Colorectal Cancer Study Group of the Arbeitsgemeinschaft Internistische Onkologie (AIO) and is a member of the Task Force Colorectal Cancer and the Board of the Gastrointestinal Cancer Study Group of the EORTC. He is a key member of several German and other international cancer societies, including the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO), where serves as Board Member and Section Editor for Gastrointestinal Cancers of the Guideline Committee.
Dr Arnold has (co-)authored more than 150 articles in peer-reviewed journals and several book chapters.
PRINT THIS PAGE
Page last modified: